US Patent 7256281 Recombinant
All edits
Edits on 16 Sep, 2023
Golden AI
Edits made to:
Infobox (+4 properties)
Infobox
Patent Inventor Names
Christian Asare Darko0
Evelina Angov0
Jeffrey A. Lyon0
Joe D. Cohen0
Edits on 1 Sep, 2023
Golden AI
Edits made to:
Article (+381 characters)
Article
Patent abstract
In this application is described the expression and purification of a recombinant Plasmodium falciparum (FVO) MSP-142. The method of the present invention produces a highly purified protein that retains folding and disulfide bridging of the native molecule. The recombinant MSP-142 is useful as a diagnostic reagent, for use in antibody production, and as a vaccine.
Edits on 15 Jul, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07256281 Recombinant US Patent 7256281 Recombinant
Infobox
Patent Number
072562810
Patent Number
72562810
Edits on 23 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 28 Mar, 2023
Golden AI
Infobox
Is a
Patent Jurisdiction
Patent Number
072562810
Date of Patent
August 14, 2007
0Patent Application Number
104046670
Date Filed
April 1, 2003
0Official Website
Patent Primary Examiner
Edits on 16 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 22 Nov, 2021
Golden AI
Edits made to:
Infobox (+7 properties)
US Patent 07256281 Recombinant
Infobox
Is a
Patent jurisdiction
Patent number
07256281
Date of patent
August 14, 2007
Patent application number
10404667
Date Filed
April 1, 2003
Patent primary examiner
Find more entities like US Patent 7256281 Recombinant
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.